Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-07T18:31:20.314Z Has data issue: false hasContentIssue false

Review of Sertoli cell dysfunction caused by COVID-19 that could affect male fertility

Published online by Cambridge University Press:  28 June 2021

Amirreza Niazi Tabar*
Affiliation:
Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran
Kiana Sojoudi
Affiliation:
Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran
Hannaneh Henduei
Affiliation:
Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran
Hossein Azizi
Affiliation:
Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran
*
Author for correspondence: Amirreza Niazi Tabar. Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran. Email: A.niazitabar@ausmt.ac.ir
Rights & Permissions [Opens in a new window]

Abstract

Spermatogenesis is a complex and elaborate differentiation process and is vital for male fertility. Sertoli cells play a major role in fertility and induce spermatogenesis by protecting, nourishing, and supporting germ cells. It has been speculated that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could directly affect the male reproductive system, and therefore heredity and fertility. The similarity of SARS-CoV-2 to SARS-CoV could confirm this hypothesis because both viruses use angiotensin-converting enzyme (ACE2) as the receptor to enter human cells. ACE2 is expressed by Sertoli cells and other testicular cells, therefore COVID-19 has the potential to impair fertility by destroying Sertoli cells. This hypothesis should be evaluated and confirmed by monitoring fertility in patients with COVID-19.

Information

Type
Review Article
Copyright
© The Author(s), 2021. Published by Cambridge University Press
Figure 0

Figure 1. Immunohistochemistry staining of Sertoli cells in mice. Blue 4′,6-diamidino-2-phenylindole (DAPI) staining of all cells within the seminiferous tubule (A1, B1). Sertoli cell staining with Sox9 (A2) and red vimentin (B2). Merged images of DAPI and Sox9 (A3) and vimentin (B3) (scale bars, 50 μm) (Azizi et al., 2021).

Figure 1

Figure 2. Fluidigm real-time RT-PCR. Highly significant expression of SOX9 (A) and vimentin (B) in Sertoli cells (SCs) compared with germ cells (GCs) (*P < 0.05) (Azizi et al., 2020).

Figure 2

Figure 3. The hypothalamus secretes a hormone called gonadotropin-releasing hormone (GnRH), which triggers the release of FSH and LH hormones from the pituitary gland. FSH stimulates Sertoli cells to secrete factors such as transferrin and lactate. It also stimulates the secretion of inhibin B from Sertoli cells, which results in negative feedback of FSH secretion. LH stimulates testosterone secretion by acting on Leydig cells, and directly affects the process of spermatogenesis (Gurung and Jialal, 2020).

Figure 3

Figure 4. Coronavirus structure and features. COVID-19 is an enveloped single-stranded RNA virus composed of envelope (E), nucleocapsid (N), spike (S) and membrane (M) proteins. Two long sequences of SARS-CoV-2 RNA encode special proteins such as an RNA-dependent RNA polymerase that is crucial for viral spread during infection. Other parts of the RNA sequence represent structural proteins including envelope, spike and nucleocapsid (Chen et al., 2020).

Figure 4

Figure 5. Coronavirus replication in host cells. The S protein in SARS-CoV-2 allows the virus to bind to the ACE2 receptor on the surface of the host cell. Once the virus enters the host cell, viral RNA is released, and then the virus uses the host cell’s ribosome as a protein-making machine to translate its genes. One of the translated proteins is an RNA-dependent RNA polymerase that is not found in eukaryotic cells and which the virus needs it for its RNA replication. Some replicated RNAs are re-translated by the host ribosome to produce the structural proteins of the virus. These then move to the rough endoplasmic reticulum and from there to the Golgi apparatus. In the Golgi apparatus, these proteins undergo modifications and combine with replicated RNAs. After packaging, a new virus is created that exits the cell by exocytosis (Millet and Whittaker, 2018).